CD8A and neoplasm: As adjuvant, λ-CGN treated HPV DC-based vaccine significantly suppressed tumor growth in TC-1 tumor mouse model, which might be correlated with the induction of HPV-specific CD8+ T cell responses, inhibition of nTregs and MDSCs, and activation of T cells.